MX2023012801A - Nueva formulacion. - Google Patents
Nueva formulacion.Info
- Publication number
- MX2023012801A MX2023012801A MX2023012801A MX2023012801A MX2023012801A MX 2023012801 A MX2023012801 A MX 2023012801A MX 2023012801 A MX2023012801 A MX 2023012801A MX 2023012801 A MX2023012801 A MX 2023012801A MX 2023012801 A MX2023012801 A MX 2023012801A
- Authority
- MX
- Mexico
- Prior art keywords
- new formulation
- formulation
- etonogestrel
- contraception
- preparing
- Prior art date
Links
- 238000009472 formulation Methods 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- GCKFUYQCUCGESZ-BPIQYHPVSA-N etonogestrel Chemical compound O=C1CC[C@@H]2[C@H]3C(=C)C[C@](CC)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 GCKFUYQCUCGESZ-BPIQYHPVSA-N 0.000 abstract 1
- 229960002941 etonogestrel Drugs 0.000 abstract 1
- 239000007972 injectable composition Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000013268 sustained release Methods 0.000 abstract 1
- 239000012730 sustained-release form Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Biomedical Technology (AREA)
- Dermatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Gynecology & Obstetrics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21305559 | 2021-04-30 | ||
| PCT/EP2022/061511 WO2022229402A1 (en) | 2021-04-30 | 2022-04-29 | New formulation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2023012801A true MX2023012801A (es) | 2023-11-08 |
Family
ID=75904839
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2023012801A MX2023012801A (es) | 2021-04-30 | 2022-04-29 | Nueva formulacion. |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240325294A1 (https=) |
| EP (1) | EP4329727A1 (https=) |
| JP (1) | JP2024516264A (https=) |
| KR (1) | KR20240006032A (https=) |
| CN (1) | CN117222402A (https=) |
| AU (1) | AU2022264844A1 (https=) |
| CA (1) | CA3217538A1 (https=) |
| MX (1) | MX2023012801A (https=) |
| WO (1) | WO2022229402A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2026013080A1 (en) | 2024-07-08 | 2026-01-15 | InnoCore Technologies Holding B.V. | Pharmaceutical composition based on biodegradable polymers comprising polyoxazoline |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2741628B1 (fr) | 1995-11-29 | 1998-02-06 | Centre Nat Rech Scient | Nouveaux hydrogels a base de copolymeres trisequences et leur application notamment a la liberation progressive de principes actifs |
| US9023897B2 (en) * | 2010-12-29 | 2015-05-05 | Medincell | Biodegradable drug delivery compositions |
| CN103446043B (zh) * | 2012-05-29 | 2015-06-17 | 辽宁省计划生育科学研究院 | 一种原位凝胶注射植入剂 |
| EP2866837B1 (en) * | 2012-06-27 | 2022-12-14 | Medincell S.A. | Biodegradable drug delivery for hydrophobic compositions |
| US10188602B2 (en) * | 2016-09-29 | 2019-01-29 | Gesea Biosciences Inc. | Bioerodible implant for long-term drug delivery and associated methods of manufacture and use |
| EP3655017B1 (en) * | 2017-07-17 | 2025-01-22 | Medincell S.A. | Pharmaceutical composition |
| KR102441064B1 (ko) * | 2017-07-17 | 2022-09-06 | 현대자동차주식회사 | 연료전지 차량의 제어 방법 |
-
2022
- 2022-04-29 CN CN202280031387.XA patent/CN117222402A/zh active Pending
- 2022-04-29 CA CA3217538A patent/CA3217538A1/en active Pending
- 2022-04-29 US US18/557,882 patent/US20240325294A1/en active Pending
- 2022-04-29 KR KR1020237041232A patent/KR20240006032A/ko active Pending
- 2022-04-29 AU AU2022264844A patent/AU2022264844A1/en active Pending
- 2022-04-29 MX MX2023012801A patent/MX2023012801A/es unknown
- 2022-04-29 JP JP2023566975A patent/JP2024516264A/ja active Pending
- 2022-04-29 EP EP22726457.9A patent/EP4329727A1/en active Pending
- 2022-04-29 WO PCT/EP2022/061511 patent/WO2022229402A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| JP2024516264A (ja) | 2024-04-12 |
| WO2022229402A1 (en) | 2022-11-03 |
| AU2022264844A1 (en) | 2023-11-23 |
| EP4329727A1 (en) | 2024-03-06 |
| US20240325294A1 (en) | 2024-10-03 |
| CA3217538A1 (en) | 2022-11-03 |
| CN117222402A (zh) | 2023-12-12 |
| KR20240006032A (ko) | 2024-01-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201902053B (en) | Pharmaceutical composition | |
| CL2016001411A1 (es) | Unidad de dosificación farmacéutica solida de desintegración oral que comprende un componente de estetrol; metodo de preparación; uso para la anticoncepción femenina y en terápia de sustitución hormonal femenina. | |
| BR112012023324B8 (pt) | processo de preparação de uma forma de dosagem multifásica liofilizada de dissolução rápida | |
| MX2021006969A (es) | Ligante peptidico. | |
| MX389310B (es) | Anticonceptivos a base de drospirenona para paciente femenina afectada con exceso de peso. | |
| WO2018165404A8 (en) | Pharmaceutical formulations of phloroglucinol and trimethylphloroglucinol | |
| PE20211588A1 (es) | Compuestos y sus usos para aliviar sintomas asociados a la menopausia | |
| PH12020550815A1 (en) | Delayed release deferiprone tablets and methods of using the same | |
| MX2017013636A (es) | Combinacion de dosis fija resistente a la manipulacion que proporciona una liberacion rapida de dos farmacos desde diferentes particulas. | |
| MY208261A (en) | Oral pharmaceutical composition | |
| MX2023012801A (es) | Nueva formulacion. | |
| MX2021005390A (es) | Ingredientes farmaceuticos activos amorfos novedosos que comprenden carbonato de magnesio mesoporoso sustancialmente amorfo. | |
| JOP20240026A1 (ar) | طريقة لعلاج بطانة الرحم وتوفير وسيلة فعالة لمنع الحمل | |
| MX2018010065A (es) | Forma de dosificacion oral que comprende rifaximina en forma beta. | |
| MX2022006502A (es) | Composiciones farmaceuticas. | |
| MY191983A (en) | Pharmaceutical formulations comprising sodium palmitoyl-l-prolyl-l-prolyl-glycyl-l-tyrosinate and methods for preparing the same | |
| ZA202003904B (en) | Drug delivery system | |
| MX2017013634A (es) | Combinacion de dosis fija resistente a la manipulacion que proporciona una liberacion rapida de dos farmacos desde particulas y un polvo. | |
| MX2017013633A (es) | Combinacion de dosis fija resistente a la manipulacion que proporciona una liberacion rapida de dos farmacos desde particulas. | |
| MX2017013643A (es) | Combinacion de dosis fija resistente a la manipulacion que proporciona una liberacion rapida de dos farmacos desde particulas y una matriz. | |
| WO2020022976A3 (en) | A formulation comprising dexketoprofen | |
| ZA202303273B (en) | New modified release oral contraceptive composition | |
| PH12020551547A1 (en) | Pharmaceutical preparation | |
| MX2021010018A (es) | Anticonceptivos unisex no hormonales. | |
| MX2021004553A (es) | Composiciones farmaceuticas y metodos para fabricar formulaciones de dosificacion solidas bajo demanda. |